ALRIB Riber SA

RIBER and the Toulouse-based LAAS-CNRS set up the joint laboratory EPICENTRE focused on MBE process optimization and automation 

RIBER and the Toulouse-based LAAS-CNRS set up the joint laboratory EPICENTRE focused on MBE process optimization and automation 

RIBER and the Toulouse-based LAAS-CNRS set up the joint laboratory EPICENTRE focused on MBE process optimization and automation 



Bezons, June 29, 2021 – 8am – RIBER, the global leader for molecular beam epitaxy (MBE) equipment serving the semiconductor industry, and the CNRS Laboratory for Analysis and Architecture of Systems (LAAS-CNRS) in Toulouse are announcing the creation of the joint laboratory EPICENTRE / LAAS - RIBER, within which they will share, for a six-year period, their respective expertise in MBE (Molecular Beam Epitaxy).

EPICENTRE serving the MBE Dream

The objective with EPICENTRE is to put in place a strategy for technological innovation in the MBE field through joint governance and a research plan designed to open up the development of a series of technological components.

The first technical pillar involves developing a series of complementary, non-destructive in-situ metrics tools that ensure ultimate control over epitaxy processes for complex materials. Its ambition is to provide solutions to significantly improve MBE processes with a view to offering increased automation, stability and reproducibility for growth processes across all of the ranges of Riber machines.

EPICENTRE’s second technical pillar is to develop a dedicated solution for superconductor materials growth for the datacom sector, focused in particular on quantum computing, specifically addressing the technological obstacle of epitaxy at cryogenic temperatures. Its ambition is to invent new hybrid epitaxially grown interfaces that will form the basic building blocks for future spintronics and quantum components.

Solutions for growing complex components (VCSEL, multi-junction solar cells) will also be developed with a view to demonstrating the efficiency, effectiveness and relevance of these in-situ metrics tools with a view to mass production.

Alongside this, EPICENTRE will launch work on machine learning, an area with strong expectations for the MBE community, looking to optimize the analysis of materials growth processes.

Program driving innovation 

This program aims to design an MBE platform, currently unrivalled on the market, focused on III-V and superconductor complex structures growth and incorporating automated advanced control processes.

The Toulouse LAAS-CNRS micro-nano technology unit will therefore soon be receiving a platform provided by Riber. This platform will be fitted with an instrumentation range that is fully integrated with Riber’s process control software Crystal XE, with features including the in-situ monitoring and control of epitaxial growth parameters. All of these parameters and the corresponding ex-situ characterizations will be compiled in a knowledge base.

This collaboration, supporting innovation, will ultimately make it possible to extend the overall approach to cover Riber’s entire range of research and production machines.

Building on a longstanding relationship

The creation of the joint laboratory EPICENTRE will further strengthen the partnership between LAAS-CNRS and Riber, which have had a close relationship for the past 35 years. Illustrating this, LAAS-CNRS has trained a number of Riber staff on MBE technology, has developed a number of demonstrators and characterizations for the Company’s clients, and is now a showcase for Riber’s know-how.

In 2019, Riber acquired the license to use a patent for an LAAS-CNRS measurement instrument, EZ Curve, enabling the real-time monitoring of substrate curvature for constrained epitaxy. This instrument, whose sales were launched by Riber at the start of 2021, makes it possible to monitor changes in constraints and determine alloy thickness and concentration levels with significantly higher precision than rival products.

The creation of EPICENTRE will make it possible to capitalize more effectively on the joint technological innovations.

Through EPICENTRE and the simplification of MBE machine use, Riber is further strengthening its value creation strategy serving semiconductor users, researchers and manufacturers.



About RIBER

RIBER is the global market leader for MBE - molecular beam epitaxy - equipment. It designs and produces MBE systems and evaporators for the semiconductor industry. It also provides technical and scientific support for its clients, maintaining their equipment and optimizing their performance and output levels. Through its high-tech equipment, RIBER performs an essential role in the development of advanced semiconductor systems that are used in numerous consumer applications, from information technologies to 5G telecommunications networks, OLED screens and next-generation solar cells. 

RIBER is a BPI France-approved innovative company and is listed on the Euronext Growth Paris market (ISIN: FR0000075954).

 

About the Laboratory for Analysis and Architecture of Systems (LAAS-CNRS)

With over 650 people, the Laboratory for Analysis and Architecture of Systems is one of the French National Centre for Scientific Research’s largest in-house research units. To anticipate the major interdisciplinary challenges relating to our rapidly evolving society, the LAAS-CNRS has identified key strategic areas based around the four core fields that have been the laboratory’s trademark since it was created in 1968: automatic systems, robotics, IT and micro and nanotechnologies. Within these disciplines, six scientific departments coordinate the activities of the 25 research teams and define the areas that we will focus on over the coming years, particularly in the space, transport, energy, industry of the future, and health / environment sectors. 

Research at LAAS requires powerful experimental facilities and technology. These resources are shared around the laboratory’s five technology platforms, which are constantly evolving.

The micro and nanotechnology platform that will house the joint laboratory’s MBE equipment is a member of the French network of high-end facilities in the field of micro and nanotechnology, Renatech. This is a 1,600 sq.m cleanroom open to collaboration with the academic world and industrial sector.





/en/ 

Contacts

RIBER  

Stéphane Berterretche  

tel: +33 (0)1 39 96 65 00 

 
LAAS 

Alexandre Arnoult 

tel: +33 (0)5 61 33 63 81 







CALYPTUS  

Cyril Combe 

tel: +33 (0)1 53 65 68 68 

 



Attachment



EN
29/06/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Riber SA

 PRESS RELEASE

RIBER: 2025 FIRST-HALF BUSINESS - FULL-YEAR REVENUES EXPECTED TO EXCEE...

RIBER: 2025 FIRST-HALF BUSINESS - FULL-YEAR REVENUES EXPECTED TO EXCEED €40M 2025 FIRST-HALF BUSINESS FULL-YEAR REVENUES EXPECTED TO EXCEED €40M Bezons, July 23, 2025 - 8:00am - RIBER, the global leader in Molecular Beam Epitaxy (MBE) equipment for the semiconductor industry, reports its revenues for the first half of 2025. Business developments At June 30 (€m)20252024ChangeSystems7.89.4-17%Services and accessories3.04.3-31%Total half-year revenues 10.713.7-22% In a complex international environment, RIBER continues to demonstrate the resilience of its business model and the app...

 PRESS RELEASE

RIBER: ACTIVITÉ DU PREMIER SEMESTRE 2025 - PERSPECTIVES DE CHIFFRE D’A...

RIBER: ACTIVITÉ DU PREMIER SEMESTRE 2025 - PERSPECTIVES DE CHIFFRE D’AFFAIRES ANNUEL SUPÉRIEUR À 40 M€ ACTIVITÉ DU PREMIER SEMESTRE 2025 PERSPECTIVES DE CHIFFRE D’AFFAIRES ANNUEL SUPÉRIEUR À 40 M€ Bezons, le 23 juillet 2025 – 8h00 – RIBER, leader mondial des équipements d’épitaxie par jets moléculaires (MBE) pour l’industrie des semi-conducteurs, annonce son chiffre d’affaires du premier semestre 2025. Évolution de l'activité En M€ - au 30 juin20252024ÉvolutionSystèmes7,89,4- 17 %Services et accessoires3,04,3- 31 %Total chiffre d’affaires semestriel10,713,7- 22 % Dans un environn...

 PRESS RELEASE

RIBER: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D’ACTIONS ET DE ...

RIBER: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL AU 30 JUIN 2025 Bezons, le 11 juillet 2025, 19h00 INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL Établi en application de l’article 223-16 du règlement général de l’Autorité des Marchés Financiers DateNombre total d’actions composant le capital socialNombre total de droits de vote  Total brut des droits de vote :21.253.02430 juin 202521.253.024Total net* des droits de vote : 20.977.655 * Total net : nombre total ...

 PRESS RELEASE

RIBER: Bilan semestriel du contrat de liquidité contracté avec la Soci...

RIBER: Bilan semestriel du contrat de liquidité contracté avec la Société de Bourse Gilbert Dupont Bilan semestriel du contrat de liquidité contracté avec la Société de Bourse Gilbert Dupont Bezons (France), le 4 juillet 2025 – 19h00 – RIBER, leader mondial des équipements d’épitaxie par jets moléculaires (MBE) pour l’industrie des semiconducteurs, publie le bilan semestriel du contrat de liquidité. Au titre du contrat de liquidité confié par la société RIBER à la Société de Bourse Gilbert Dupont, à la date du 30 juin 2025, les moyens suivants figuraient au compte de liquidité : No...

 PRESS RELEASE

RIBER: Descriptif du programme du programme de rachat d’actions

RIBER: Descriptif du programme du programme de rachat d’actions Mise en œuvre du programme de rachat d’actions Descriptif du programme Bezons, le 20 juin 2025 – 19h00 – RIBER, leader mondial des équipements d’épitaxie par jets moléculaires (MBE) pour l’industrie des semi-conducteurs, publie les principales caractéristiques de son programme de rachat d'actions. I. Cadre juridique En application des articles 241-1 et suivants du Règlement Général de l’Autorité des Marchés Financiers et du règlement européen (EU) n°596/2014 du 16 avril 2014 sur les abus de marché, ainsi que des règlement...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch